Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation, oestrogen and the menopause.

M Notelovitz

    Clinics in Obstetrics and Gynaecology
    |April 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Oestrogen replacement therapy (ORT) aims to prevent menopause-related issues. Current evidence suggests ORT does not increase the risk of arterio-venous thrombosis in postmenopausal women.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estradiol absorption from vaginal tablets in postmenopausal women.

    Obstetrics and gynecology·2002
    Same author

    Effects of estrogen/androgen therapy on bone mineral density parameters.

    The Journal of reproductive medicine·2001
    Same author

    Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17beta-estradiol.

    Menopause (New York, N.Y.)·2000
    Same author

    The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara).

    Menopause (New York, N.Y.)·2000
    Same author

    Urogenital atrophy and low-dose vaginal estrogen therapy.

    Menopause (New York, N.Y.)·2000
    Same author

    Initial 17beta-estradiol dose for treating vasomotor symptoms.

    Obstetrics and gynecology·2000

    Area of Science:

    • Reproductive endocrinology
    • Thrombosis research
    • Hormone therapy

    Background:

    • Menopause is associated with oestrogen deficiency, leading to potential pathologies.
    • Postmenopausal women may have altered coagulation factors and reduced peripheral blood flow, increasing clot formation risk.
    • A controversial link exists between oestrogens, oral contraceptives, and thrombosis.

    Purpose of the Study:

    • To evaluate the risk of thrombosis associated with oestrogen replacement therapy (ORT) in postmenopausal women.
    • To investigate the potential for oestrogen-induced alterations in coagulation mechanisms.
    • To address the paradox between known risk factors for thrombosis and the lack of identified ORT-specific risks.

    Main Methods:

    • Review of existing clinical reports and longitudinal studies on oestrogen replacement therapy.

    Related Experiment Videos

  • Analysis of coagulation factor changes and peripheral blood flow in elderly populations.
  • Comparison with data on oral contraceptives and thrombosis.

    • Main Results:

    • No long-term studies have definitively linked oestrogen use in "normal" postmenopausal women to thrombosis.
    • The study notes physiological changes in the elderly that predispose to clot formation.
    • The precise role of oestrogen type and potency in ORT-related thrombosis remains undetermined.

    Conclusions:

    • Oestrogen replacement therapy (ORT) per se does not appear to elevate the risk of arterio-venous thrombosis in postmenopausal women.
    • Further research is needed to clarify the influence of different oestrogen types and potencies.
    • The current evidence does not support a direct causal link between ORT and increased thrombosis risk.